» Articles » PMID: 33352721

Transferrin Receptors in Erythropoiesis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Dec 23
PMID 33352721
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Erythropoiesis is a highly dynamic process giving rise to red blood cells from hematopoietic stem cells present in the bone marrow. Red blood cells transport oxygen to tissues thanks to the hemoglobin comprised of α- and β-globin chains and of iron-containing hemes. Erythropoiesis is the most iron-consuming process to support hemoglobin production. Iron delivery is mediated via transferrin internalization by the endocytosis of transferrin receptor type 1 (TFR1), one of the most abundant membrane proteins of erythroblasts. A second transferrin receptor-TFR2-associates with the erythropoietin receptor and has been implicated in the regulation of erythropoiesis. In erythroblasts, both transferrin receptors adopt peculiarities such as an erythroid-specific regulation of TFR1 and a trafficking pathway reliant on TFR2 for iron. This review reports both trafficking and signaling functions of these receptors and reassesses the debated role of TFR2 in erythropoiesis in the light of recent findings. Potential therapeutic uses targeting the transferrin-TFR1 axis or TFR2 in hematological disorders are also discussed.

Citing Articles

Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism.

Taciak B, Bialasek M, Kubiak M, Marszalek I, Gorczak M, Osadchuk O Nat Commun. 2025; 16(1):1327.

PMID: 39900573 PMC: 11790938. DOI: 10.1038/s41467-025-56637-9.


An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA.

Castruccio Castracani C, Breda L, Papp T, Guerra A, Radaelli E, Assenmacher C Blood. 2024; 145(1):98-113.

PMID: 39656107 PMC: 11738033. DOI: 10.1182/blood.2024025846.


Single-cell multi-omics map of human fetal blood in Down syndrome.

Marderstein A, De Zuani M, Moeller R, Bezney J, Padhi E, Wong S Nature. 2024; 634(8032):104-112.

PMID: 39322663 PMC: 11446839. DOI: 10.1038/s41586-024-07946-4.


Transferrin receptor targeting chimeras for membrane protein degradation.

Zhang D, Duque-Jimenez J, Facchinetti F, Brixi G, Rhee K, Feng W Nature. 2024; 638(8051):787-795.

PMID: 39322661 PMC: 11839386. DOI: 10.1038/s41586-024-07947-3.


Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome.

Donovan M, Rachubinski A, Smith K, Araya P, Waugh K, Enriquez-Estrada B Cell Rep. 2024; 43(8):114599.

PMID: 39120971 PMC: 11479675. DOI: 10.1016/j.celrep.2024.114599.


References
1.
Cao H, Chen J, Krueger E, McNiven M . SRC-mediated phosphorylation of dynamin and cortactin regulates the "constitutive" endocytosis of transferrin. Mol Cell Biol. 2009; 30(3):781-92. PMC: 2812239. DOI: 10.1128/MCB.00330-09. View

2.
Di Savino A, Gaidano V, Palmieri A, Crasto F, Volpengo A, Lorenzatti R . Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes. Br J Haematol. 2016; 176(3):491-495. DOI: 10.1111/bjh.13968. View

3.
Kerenyi M, Grebien F, Gehart H, Schifrer M, Artaker M, Kovacic B . Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood. 2008; 112(9):3878-88. PMC: 2976851. DOI: 10.1182/blood-2008-02-138339. View

4.
Schranzhofer M, Schifrer M, Cabrera J, Kopp S, Chiba P, Beug H . Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood. 2006; 107(10):4159-67. DOI: 10.1182/blood-2005-05-1809. View

5.
He J, Fan K, Yan X . Ferritin drug carrier (FDC) for tumor targeting therapy. J Control Release. 2019; 311-312:288-300. DOI: 10.1016/j.jconrel.2019.09.002. View